We are delighted to share with you an exciting update: our endeavors have been spotlighted not once, but twice in the esteemed pages of Unict magazine! Article #1: Delve into an exploration of Mimesis. From its conceptualization to its present iteration, uncover how innovation drives our progress. Article #2: Prepare for a momentous revelation! We …
Leggi tutto “Double Feature: Highlighted Twice in Unict Magazine!”
Advancing Towards Regulatory Recognition: Mimesis S.r.l.’s Groundbreaking Effort In a world-first, Mimesis S.r.l., within the innovative In Silico World (ISW) Consortium (https://www.insilico.world), has secured preliminary regulatory acceptance from the European Medicine Agency (EMA) for its UISS-TB-DR simulation platform. This groundbreaking achievement not only marks a historic moment for tuberculosis (TB) vaccine development but also opens …
It is an honour for us to have become part of this Alliance, which will certainly lead us to grow and learn a lot, both as a company and as people. Let us hope that this is the beginning of a long and worthwhile journey. Click on this link to find out more:https://avicenna-alliance.com/latest-news/news/mimesis-is-a-new-avicenna-member/